Clinical Trials Directory

Trials / Completed

CompletedNCT01511991

Sevoflurane's Effect on Mitral Valve Annular Velocity in Cardiac Surgery

Sevoflurane's Effect on Tissue Doppler Profiles of Lateral Mitral Annulus During Cardiac Surgery

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Konkuk University Medical Center · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine sevoflurane's dose-dependent effect on left ventricular (LV) function in cardiac surgery. The change of tissue Doppler imaging (TDI) of lateral mitral valve annular velocity at three different sevoflurane concentrations would be analyzed by using intraoperative transesophageal echocardiography (TEE)in cardiac surgery patients.

Detailed description

Following data would be determined after 10 min-exposure to each dosage of sevoflurane with 1.0, 2.0 and 3.0 inspired vol% (T1, T2 and T3, respectively) during remifentanil-based anesthesia (1.0 mcg/kg/min) for cardiac surgery (n=14): 1. TDI of lateral mitral annulus at systole (S'), early filling (E') and atrial contraction (A') 2. transmitral flow Doppler at early filling (E), atrial contraction (A), deceleration time; 3. LV-ejection fraction (EF) 4. bispectral index (BIS) 5. phenylephrine-infusion rate 6. other pressure derived hemodynamic parameters:heart rate; systolic, diastolic, and mean blood pressures; systolic, diastolic, and mean pulmonary artery pressures; central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), mixed venous O2 saturation (SvO2), cardiac index (CI) and stroke volume index (SVI)

Conditions

Interventions

TypeNameDescription
DRUGSevoflurane dosage titrationcomparisons of the effect of the 10 min-inhalation of each concentration of sevoflurane, 1.0 inspired vol%, 2.0 inspired vol% and 3.0 inspired vol% (T1, T2 and T3)

Timeline

Start date
2009-05-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2012-01-19
Last updated
2015-02-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01511991. Inclusion in this directory is not an endorsement.